Iori Matsuda
Papers
1
Total Citations
5
H-Index
1
About
Dr. Iori Matsuda is a leading urologic oncologist whose research focuses on refining risk stratification and treatment strategies for prostate cancer, particularly through the lens of Gleason grading. His most-cited work, a 2021 study on predictive factors for pathological downgrading after prostatectomy, addresses a critical clinical challenge: the discrepancy between biopsy and final pathology in patients with high-risk Gleason scores 4+3 and 4+4. By demonstrating that the proportion of Gleason pattern 4 at biopsy significantly impacts risk assessment, Dr. Matsuda has provided clinicians with a more nuanced tool for predicting patient outcomes and avoiding overtreatment. This contribution, cited 5 times, underscores his commitment to improving prognostic accuracy. His broader research portfolio explores the intersection of pathological features and surgical decision-making, aiming to personalize care for men with prostate cancer. Dr. Matsuda’s work is essential reading for urologists and pathologists seeking to bridge the gap between biopsy findings and definitive treatment, ultimately enhancing the precision of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1